{
    "root": "5b544e76-1c59-46e9-8152-1f3e1e377930",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Metronidazole",
    "value": "20250430",
    "ingredients": [
        {
            "name": "METRONIDAZOLE",
            "code": "140QMO216E"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "SODIUM PHOSPHATE, DIBASIC",
            "code": "GR686LBA74"
        }
    ],
    "indications": null,
    "contraindications": ", rate , duration treatment individualized depend upon indication , patient ’ age , weight , condition concomitant treatment , patient ’ laboratory response treatment .",
    "warningsAndPrecautions": "metronidazole injection , usp supplied 100 ml single dose plastic containers , containing iso-osmotic , buffered solution 500 mg metronidazole follows : 2b3422 ndc 0338-9541-24 500 mg/100 ml store controlled room temperature ( 77°f 25°c ) protect light storage . remove unit overwrap ready . overwrap moisture barrier . inner bag maintains sterility product . removing overwrap , check minute leaks squeezing inner bag firmly . leaks found , discard solution sterility may impaired .",
    "adverseReactions": "• hypersensitivity metronidazole injection contraindicated patients prior history hypersensitivity metronidazole nitroimidazole derivatives . • psychotic reaction disulfiram oral metronidazole associated psychotic alcoholic patients using disulfiram concurrently . administer metronidazole patients taken disulfiram within last two weeks ( precautions-drug ) . • interaction alcohol oral metronidazole associated disulfiram-like reaction alcohol , including abdominal cramps , nausea , vomiting , headaches , flushing . discontinue consumption alcohol products containing propylene glycol least three days therapy metronidazole ( precautions-drug ) . • cockayne syndrome metronidazole injection contraindicated patients cockayne syndrome . severe irreversible hepatotoxicity/acute liver failure fatal outcomes reported initiation metronidazole patients cockayne syndrome ( ) .",
    "contraindications_original": "Dosage, rate of administration, and duration of treatment are to be individualized and depend upon the indication for use, the patient’s age, weight, clinical condition and concomitant treatment, and on the patient’s clinical and laboratory response to the treatment.",
    "warningsAndPrecautions_original": "Metronidazole Injection, USP is supplied in 100 mL single dose plastic containers, each containing an iso-osmotic, buffered solution of 500 mg metronidazole as follows: \n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                              2B3422\n                           \n                           \n                              NDC 0338-9541-24\n                           \n                           \n                              500 mg/100 mL\n                           \n                        \n                     \n                  \n                  Store at controlled room temperature (77°F or 25°C) and protect from light during storage. Do not remove unit from overwrap until ready for use. The overwrap is a moisture barrier. The inner bag maintains the sterility of the product. After removing overwrap, check for minute leaks by squeezing inner bag firmly. If leaks are found, discard solution as sterility may be impaired.",
    "adverseReactions_original": "•\n                        Hypersensitivity\n                        Metronidazole Injection is contraindicated in patients with a prior history of hypersensitivity to metronidazole or other nitroimidazole derivatives.\n                     \n                        •\n                        Psychotic Reaction with Disulfiram\n                        Use of oral metronidazole is associated with psychotic reactions in alcoholic patients who were using disulfiram concurrently. Do not administer metronidazole to patients who have taken disulfiram within the last two weeks (see PRECAUTIONS-Drug Interactions).\n                     \n                        •\n                        Interaction with Alcohol\n                        Use of oral metronidazole is associated with a disulfiram-like reaction to alcohol, including abdominal cramps, nausea, vomiting, headaches, and flushing. Discontinue consumption of alcohol or products containing propylene glycol during and for at least three days after therapy with metronidazole (see PRECAUTIONS-Drug Interactions).\n                     \n                        •\n                        Cockayne Syndrome\n                        Metronidazole Injection is contraindicated in patients with Cockayne syndrome. Severe irreversible hepatotoxicity/acute liver failure with fatal outcomes have been reported after initiation of metronidazole in patients with Cockayne syndrome (see ADVERSE REACTIONS)."
}